InflaRx N.V. Common Stock

IFRXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
2.61 USD
↗ 0.14 (5.67%)AT CLOSE (11:59 AM EDT)
2.62
↗ 0.01 (0.38%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
2.62
↗ 0.01 (0.38%)
🔴Market: CLOSED
Open?$2.52
High?$2.70
Low?$2.51
Prev. Close?$2.47
Volume?1.5M
Avg. Volume?N/A
VWAP?$2.64
Bid / Ask
Bid?$2.56 × 1.0K
Ask?$2.66 × 1.9K
Spread?$0.10
Midpoint?$2.61
Valuation & Ratios
Market Cap?384.4M
Shares Out?72.3M
Float?63.4M
Float %?93.6%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

IFRX is currently priced at $2.61. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, a bullish Golden Cross on the moving averages and bullish moving average alignment.

Technical & fundamental data as of May 22, 2026.

News
Profile
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
Themes
Biotech - Drug Development›Immunology & Autoimmune
Employees
65
Market Cap
384.4M
Industry
N/A
Website
www.inflarx.de
Listed
2017-11-08
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
56
Piotroski F-Score?0/9Weak
Altman Z-Score?7.71Safe
Confidence?38%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.14%Low
Short Interest?2.0M
Days to Cover?1.0
Free Float63.4M
Avg Daily Volume2.1M
Settlement Date2026-04-30
MarketsMoversWatchlist